veglin (VEGF-AS) / VasGene - LARVOL DELTA

COATS-VEGF: Interest of Intravitreal Injections of Anti-VEGF as Initial and Adjuvant Treatment in Coats Disease (clinicaltrials.gov) - P3; N=30; Recruiting; Sponsor: Fondation Ophtalmologique Adolphe de Rothschild; Initiation date: Aug 2019 ➔ Nov 2019

Clinical • Trial initiation date

COATS-VEGF: Interest of Intravitreal Injections of Anti-VEGF as Initial and Adjuvant Treatment in Coats Disease (clinicaltrials.gov) - P3; N=30; Recruiting; Sponsor: Fondation Ophtalmologique Adolphe de Rothschild; Not yet recruiting ➔ Recruiting

Clinical • Enrollment open

COATS-VEGF: Interest of Intravitreal Injections of Anti-VEGF as Initial and Adjuvant Treatment in Coats Disease (clinicaltrials.gov) - P3; N=30; Not yet recruiting; Sponsor: Fondation Ophtalmologique Adolphe de Rothschild

Clinical • New P3 trial